David Arrington
Investor Relations and Corporate Affairs
Head of Investor Relations
Head of Investor Relations
Earnings-call appearances
-
Revolution Medicines, Inc. Q2 FY2022 Earnings Call2022-08-09
Revolution Medicines, Inc. (RVMD)
-
Coherus Oncology, Inc. Q2 FY2020 Earnings Call2020-08-06
Coherus Oncology, Inc. (CHRS)
-
Coherus Oncology, Inc. Q1 FY2020 Earnings Call2020-05-07
Coherus Oncology, Inc. (CHRS)